Researchers find 4 potential COVID treatments through AI

Using the power of artificial intelligence, Taiwan researchers have found four drugs that may be able to inhibit the COVID virus. One promising drug is JMY206, an anti-inflammatory therapy that was dozens of times more effective against COVID-19 than Remdesivir. Partial results of this study were published in ACS Nano, a journal by the American Chemical Society.

The research team at National Yang Ming Chiao Tung University used AI and SARS datasets to identify key proteases in the COVID virus and see whether different FDA-approved drugs could inhibit them. Three other drugs that showed promise against the COVID virus were hepatitis C treatments Boceprevir and Telaprevir, as well as Nelfinavir, which treats HIV.